Skip to main content
Article
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
Journal of Neuro-oncology (2016)
  • Yazmin Odia, Columbia University
  • Fabio M. Iwamoto, Columbia University
  • Argirios Moustakas, University of Vermont
  • Tyler J. Fraum, Washington University in St. Louis
  • Carlos A. Salgado, University of Maryland, Baltimore
  • Aiguo Li, National Institutes of Health
  • Teri N. Kreisl, Columbia University
  • Joohee Sul, Silver Spring Networks
  • John A. Butman, National Institutes of Health
  • Howard A. Fine, NewYork–Presbyterian Hospital
Publication Date
March 1, 2016
DOI
10.1007/s11060-015-2020-x
Citation Information
Yazmin Odia, Fabio M. Iwamoto, Argirios Moustakas, Tyler J. Fraum, et al.. "A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas" Journal of Neuro-oncology Vol. 127 Iss. 1 (2016) p. 127 - 135
Available at: http://works.bepress.com/yazmin-odia/1/